-
Mashup Score: 0Patients With Small Cell Lung Cancer That Metastasizes to the Brain May Benefit From Stereotactic Radiosurgery. Here's What We Know - 1 year(s) ago
SCLC has a higher tendency than other solid tumors to metastasize to the brain, which can cause significant morbidity and mortality.
Source: ASCO Daily NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0
For Lorna H. McNeill, PhD, MPH, researching health disparities and looking for equitable interventions to address these disparities is nothing new. Dr. McNeill, professor and chair of the Department of Health Disparities Research at The University of Texas MD Anderson Cancer Center, has been working toward these goals for almost 30 years.
Source: ASCO Daily NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#ASCODailyNews profiles #GI23 keynote speaker @McNeill_Dr of @MDAndersonNews, who encourages working together to eliminate health disparities and reduce excess mortality in minority populations: https://t.co/5YJjAR2AUr #healthequity
-
-
Mashup Score: 1State-Based Adoption of Medicaid Expansion: Illuminating the Hidden Effect on National Racial Cancer Disparities - 1 year(s) ago
The Affordable Care Act of 2010 (ACA) included an optional Medicaid expansion provision offering additional federal funding to broaden Medicaid eligibility criteria and cover preventative care for Medicaid-insured patients in participating states.
Source: ASCO Daily NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Drs. Rebecca A. Snyder and @ColonCancerDoc of @MDAndersonNews discuss the dire implications of optional state-level Medicaid expansion on national racial health disparities: https://t.co/uKLHTScNKc #GI23 #ASCODailyNews #healthequity
-
-
Mashup Score: 0HoLISTIC Consortium Develops Reliable Predictive Model for 5-Year Survival in Classic Hodgkin Lymphoma - 1 year(s) ago
The multivariable Advanced-stage classic Hodgkin lymphoma (cHL) International Prognostication Index (A-HIPI), built upon the International Prognostic Score (IPS), demonstrated reliable and accurate predictive value for 5-year progression-free survival (PFS) and 5-year overall survival (OS) in patients with newly diagnosed, advanced-stage cHL.
Source: ASCO Daily NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
New #JCO research: HoLISTIC Consortium develops reliable predictive model for 5-year survival in classic #Hodgkin lymphoma: https://t.co/DC6FSHedwo #lymsm #ASCODailyNews
-
-
Mashup Score: 2What's Next for Immunotherapy in Biliary Tract Cancers? - 1 year(s) ago
The combination of gemcitabine and cisplatin (GC) has been considered the standard of care for the first-line treatment of patients with advanced biliary tract cancer (BTC) for more than a decade.
Source: ASCO Daily NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Beyond TOPAZ-1: What’s next for IO in the treatment of #BiliaryTract cancers? Two GI medical oncologists at @MDAndersonNews investigate for #ASCODailyNews: https://t.co/NEqaXJlVX4 #GI23 #gicsm
-
-
Mashup Score: 0Liver Transplantation as Treatment for Liver Malignancies: A New Era Dawns in Transplant Oncology - 1 year(s) ago
Transplant oncology is a concept that was developed to combine the applications of transplant medicine, oncology, and surgery to treat primary and metastatic liver cancers.
Source: ASCO Daily NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
With #GI23 just around the corner, @sapisochin, @WJChoiMD & @graokane of @pmcancercentre discuss the future of liver transplantation as treatment for HCC, unresectable colorectal liver metastases, and intrahepatic cholangiocarcinoma: https://t.co/CCzSSR4tgR #ASCODailyNews #gicsm
-
-
Mashup Score: 0Incidence of Contralateral Breast Cancers Among Pathogenic Variant Carriers Could Guide Management Decisions - 1 year(s) ago
There will now be more information available to help guide treatment decisions related to contralateral breast cancer (CBC) in women with breast cancer who are carriers of germline pathogenic variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2.
Source: ASCO Daily NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
New #JCO data on contralateral risk for women w/ breast cancer and germline PVs could help guide treatment decisions: https://t.co/upbzTvuj3I #bcsm #ASCODailyNews
-
-
Mashup Score: 0The Landscape of Rectal Cancer Care Centralization: Defining Centers of Excellence in the United States - 1 year(s) ago
Rectal cancer care has become increasingly complex as multidisciplinary approaches and treatment sequencing are tailored to individual tumor characteristics and patient needs.
Source: ASCO Daily NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
For #ASCODailyNews, Drs. Alexander Fisher and Karyn Stitzenberg of @UNC_SOM review the state of U.S. #RectalCancer care standardization and the latest updates in NAPRC accreditation: https://t.co/QGM3jkjQgg #GI23 #crcsm
-
-
Mashup Score: 2
Intrahepatic cholangiocarcinoma (ICC) is an aggressive cancer, with poor outcomes resulting from late-stage diagnosis and limited treatment options for patients with advanced disease.
Source: ASCO Daily NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
For #ASCODailyNews, @gioncdoc and @drjasonstarr of @MayoClinic explore the role of liver-directed therapies in intrahepatic #cholangiocarcinoma: https://t.co/0aAEL5JIPQ #GI23 #gicsm
-
-
Mashup Score: 0Triplet Therapy Has a Place in Metastatic Hormone-Sensitive Prostate Cancer Treatment, But For Whom? - 1 year(s) ago
Despite advances in molecular diagnostics, patients with prostate cancer are currently still treated in a predominantly “one-size-fits-all” paradigm, with only clinical characteristics such as the volume of disease or the location of metastases forming the nodes in treatment decision trees.
Source: ASCO Daily NewsCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
What do ENZAMET, PEACE-1, and ARASENS tell us about triplet therapy in patients with #mHSPC? Drs. @TDorffOnc and Sandy Liu break down the data for #ASCODailyNews: https://t.co/jiIu8AsbTg #pcsm
-
Patients with #SCLC that metastasize to the brain may benefit from stereotactic radiosurgery. KOLs break down what is known regarding patient selection for #ASCODailyNews: https://t.co/u9XENqboh8 @jainprantesh #lcsm